Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 11, 2018
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
Mon, September 10, 2018
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
Fri, September 7, 2018
[ Fri, Sep 07th 2018
] - WOPRAI
[ Fri, Sep 07th 2018
] - WOPRAI
[ Fri, Sep 07th 2018
] - WOPRAI
[ Fri, Sep 07th 2018
] - WOPRAI
Vamil Divan Downgraded (TEVA) to Hold and Decreased Target to $23 on, Sep 7th, 2018
Vamil Divan of Credit Suisse, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $25 to $23 on, Sep 7th, 2018.
Vamil has made no other calls on TEVA in the last 4 months.
There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 4 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $23 on, Monday, August 6th, 2018
- David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $20 on, Friday, August 3rd, 2018
- Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
- Jacob Hughes of "Wells Fargo" Upgraded from Sell to Hold on, Monday, June 18th, 2018
This is the rating of the analyst that currently disagrees with Vamil
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $25 on, Thursday, May 31st, 2018
